AT248912T
Therapeutic antiangiogenic compositions and methods
Abstract
The inhibitor is present invention relates to an antibody capable of wherein the tumour is the abate endothelial cell proliferation inhibitor is introduced to about 20kDa, and equal to THE film adhesive C- end fragment and) treatment and wherein the related disease method.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
52 members in 17 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 583595 | United States of America | P | |
| 2307096 | United States of America | P | |
| 2626396 | United States of America | P | |
| 74016896 | United States of America | A | |
| 9616925 | United States of America | W |
Members52
| Document | Office | Kind | |
|---|---|---|---|
| CA2235393A1 | Canada | A1 | |
| WO9715666A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7466696A | Australia | A | |
| NO981803D0 | Norway | D0 | |
| NO981803L | Norway | L | |
| CZ117798A3 | Czechia | A3 | |
| EP0857210A1 | European Patent Office (EPO) | A1 | |
| NZ321356A | New Zealand | A | |
| CN1202932A | China | A | |
| US5854205A | United States of America | A | |
| KR19990066981A | Republic of Korea | A | |
| BR9611174A | Brazil | A | |
| AU717277B2 | Australia | B2 | |
| CA2348774A1 | Canada | A1 | |
| WO0026368A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1907200A | Australia | A | |
| WO0026368A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0026368A9 | World Intellectual Property Organization (WIPO) | A9 | |
| US6174861B1 | United States of America | B1 | |
| EP1124952A2 | European Patent Office (EPO) | A2 | |
| JP2002501362A | Japan | A | |
| US6346510B1 | United States of America | B1 | |
| US2002086352A1 | United States of America | A1 | |
| US2002123458A1 | United States of America | A1 | |
| US2002127595A1 | United States of America | A1 | |
| US2002155987A1 | United States of America | A1 | |
| US6544758B2 | United States of America | B2 | |
| US2003087393A1 | United States of America | A1 | |
| US2003114370A1 | United States of America | A1 | |
| EP0857210B1 | European Patent Office (EPO) | B1 | |
| AT248912TThis record | Austria | T | |
| ATE248912T1 | Austria | T1 | |
| US6630448B2 | United States of America | B2 | |
| DE69629826D1 | Germany | D1 | |
| US2003219426A1 | United States of America | A1 | |
| DK0857210T3 | Denmark | T3 | |
| ES2206602T3 | Spain | T3 | |
| US2004102372A1 | United States of America | A1 | |
| US6746865B1 | United States of America | B1 | |
| DE69629826T2 | Germany | T2 | |
| US6764995B2 | United States of America | B2 | |
| JP2004236662A | Japan | A | |
| US2005282253A1 | United States of America | A1 | |
| US7101979B1 | United States of America | B1 | |
| JP3840262B2 | Japan | B2 | |
| US7179608B2 | United States of America | B2 | |
| IL124153A | Israel | A | |
| US7495089B2 | United States of America | B2 | |
| US2009137518A1 | United States of America | A1 | |
| US7655458B2 | United States of America | B2 | |
| CA2235393C | Canada | C | |
| US7867975B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 96936842
Titles2
- German
- THERAPEUTISCHE ANTIANGIOGENISCHE ZUSAMMENSETZUNGEN UND VERFAHREN
- English
- THERAPEUTIC ANTIANGIOGENIC COMPOSITIONS AND METHOD
Classification
- CPC, 12
- C07K14/78
- A61K38/00
- A61P1/00
- Y10S435/81
- A61P1/04
- Y10S530/84
- A61P7/00
- A61P9/10
- A61P17/00
- A61P27/02
- A61P29/00
- A61P35/00
- IPC, 25
- A61K38 00
- A61K38 17
- A61K38 48
- A61K39 395
- A61K48 00
- A61P35 00
- C07H21 04
- C07K14 575
- C07K14 78
- C07K16 18
- C12N1 15
- C12N1 19
- C12N1 21
- C12N15 09
- C12N15 12
- C12N5 06
- C12N5 10
- C12N7 00
- C12P21 02
- C12P21 08
- G01N33 15
- G01N33 50
- G01N33 53
- G01N33 566
- G01N33 577